Home/ Stocks/ CDXS

Codexis, Inc.

CDXS XNAS

$1.47 -0.01 (-0.68%) ▼ 15-min delayed

Open

$1.49

High

$1.50

Low

$1.46

Volume

764.6K

Market Cap

$159.19M

About Codexis, Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Sector: INDUSTRIAL ORGANIC CHEMICALS Employees: 146 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$15.25M	$-8,704,000	$-0.10
FY 2025	$70.39M	$-43,974,000	$-0.50
Q3 2025	$8.60M	$-19,615,000	$-0.22
Q1 2025	$7.54M	$-20,688,000	$-0.25

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for CDXS yet. Check out our latest market news or earnings calendar.

Get CDXS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Codexis, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.